Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Revue Medicale De Liege
|
October 1, 1975
[A case of Hodgkin's disease]
A Moureau, M Delforge
Health Physics
|
April 6, 2023
Take a Swipe at Actinide Bioavailability: Application of a New In Vitro Method
N M Griffiths, A Moureau, S Coudert, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
November 2, 2020
Evidence for a differential translocation of actinides across human lung epithelial cell monolayer in vitro according to their physicochemical properties and the presence of a chelating agent
A Van der Meeren, G Drouet, K Devilliers, et al.
Health Physics
|
June 30, 2016
Forecasting the In Vivo Behavior of Radiocontaminants of Unknown Physicochemical Properties Using a Simple In Vitro Test
N M Griffiths, S Coudert, A Moureau, et al.
Epidemiology and Infection
|
May 27, 2017
Indonesian dengue burden estimates: review of evidence by an expert panel
T Y M Wahyono, J Nealon, S Beucher, et al.
Revue Medicale De Liege
|
April 19, 2000
[Endoscopic ultrasonography in the diagnosis and staging of pancreatic and ampullary cancer: influence on patient management]
V Gillard, M Delforge, J C Demoulin, et al.
Chemico-Biological Interactions
|
May 29, 2016
Penetration and decontamination of americium-241 ex vivo using fresh and frozen pig skin
A Tazrart, M A Bolzinger, A Moureau, et al.
Revue Medicale De Liege
|
April 19, 2000
[Epidemiological aspects, risk factors, and detection of pancreatic cancer]
M Delforge, O Plomteux, J C Demoulin, et al.
Asia-Pacific Journal of Public Health
|
February 16, 2017
Three Decades of Dengue Surveillance in Five Highly Endemic South East Asian Countries
T A Wartel, A Prayitno, S R S Hadinegoro, et al.
Vaccine: X
|
July 28, 2022
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
S Mangarule, S Palkar, M Mitra, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Revue Medicale De Liege
|
October 1, 1975
[A case of Hodgkin's disease]
A Moureau, M Delforge
Health Physics
|
April 6, 2023
Take a Swipe at Actinide Bioavailability: Application of a New In Vitro Method
N M Griffiths, A Moureau, S Coudert, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
November 2, 2020
Evidence for a differential translocation of actinides across human lung epithelial cell monolayer in vitro according to their physicochemical properties and the presence of a chelating agent
A Van der Meeren, G Drouet, K Devilliers, et al.
Health Physics
|
June 30, 2016
Forecasting the In Vivo Behavior of Radiocontaminants of Unknown Physicochemical Properties Using a Simple In Vitro Test
N M Griffiths, S Coudert, A Moureau, et al.
Epidemiology and Infection
|
May 27, 2017
Indonesian dengue burden estimates: review of evidence by an expert panel
T Y M Wahyono, J Nealon, S Beucher, et al.
Revue Medicale De Liege
|
April 19, 2000
[Endoscopic ultrasonography in the diagnosis and staging of pancreatic and ampullary cancer: influence on patient management]
V Gillard, M Delforge, J C Demoulin, et al.
Chemico-Biological Interactions
|
May 29, 2016
Penetration and decontamination of americium-241 ex vivo using fresh and frozen pig skin
A Tazrart, M A Bolzinger, A Moureau, et al.
Revue Medicale De Liege
|
April 19, 2000
[Epidemiological aspects, risk factors, and detection of pancreatic cancer]
M Delforge, O Plomteux, J C Demoulin, et al.
Asia-Pacific Journal of Public Health
|
February 16, 2017
Three Decades of Dengue Surveillance in Five Highly Endemic South East Asian Countries
T A Wartel, A Prayitno, S R S Hadinegoro, et al.
Vaccine: X
|
July 28, 2022
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
S Mangarule, S Palkar, M Mitra, et al.
Page
of 2